Original Publication Date: 1 May, 2014
Publication / Source: CNS Oncology
Authors: Anna Minchom, Ken C Yu, Jaishree Bhosle & Mary O'Brien
The epidemiology of non-small-cell lung cancer (NSCLC) has changed with a new pattern of disease emerging – a form of adenocarcinoma in mostly younger female patients, who are never or light smokers and more frequently in East Asian populations. Description of EGF receptor (EGFR) mutations has allowed new management strategies to evolve. Oral targeted therapies have broadened the treatment options in the advanced setting with the potential for periods of long term response.